Karunakaran, Mohindar M. http://orcid.org/0009-0007-4253-3779
Subramanian, Hariharan http://orcid.org/0000-0001-5409-4856
Jin, Yiming
Mohammed, Fiyaz
Kimmel, Brigitte
Juraske, Claudia
Starick, Lisa
Nöhren, Anna
Länder, Nora
Willcox, Carrie R. http://orcid.org/0000-0003-4532-1468
Singh, Rohit http://orcid.org/0000-0002-4235-8436
Schamel, Wolfgang W. http://orcid.org/0000-0003-4496-3100
Nikolaev, Viacheslav O. http://orcid.org/0000-0002-7529-5179
Kunzmann, Volker
Wiemer, Andrew J. http://orcid.org/0000-0002-3029-1780
Willcox, Benjamin E. http://orcid.org/0000-0002-6113-2109
Herrmann, Thomas http://orcid.org/0000-0002-1093-0194
Article History
Received: 16 February 2023
Accepted: 21 September 2023
First Online: 22 November 2023
Competing interests
: B.E.W. provides consultancy regarding the development of γδ T cell immunotherapy approaches for Ferring Ventures SA, linked to Ferring Pharmaceuticals. T.H. is supported by Byondis B.V. for work not related to this study.